AIMC Topic: Antigen-Antibody Reactions

Clear Filters Showing 1 to 6 of 6 articles

AlphaBind, a domain-specific model to predict and optimize antibody-antigen binding affinity.

mAbs
Antibodies are versatile therapeutic molecules that use combinatorial sequence diversity to cover a vast fitness landscape. Designing optimal antibody sequences, however, remains a major challenge. Recent advances in deep learning provide opportuniti...

DeepInterAware: Deep Interaction Interface-Aware Network for Improving Antigen-Antibody Interaction Prediction from Sequence Data.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Identifying interactions between candidate antibodies and target antigens is a key step in developing effective human therapeutics. The antigen-antibody interaction (AAI) occurs at the structural level, but the limited structure data poses a signific...

MVSF-AB: accurate antibody-antigen binding affinity prediction via multi-view sequence feature learning.

Bioinformatics (Oxford, England)
MOTIVATION: Predicting the binding affinity between antigens and antibodies accurately is crucial for assessing therapeutic antibody effectiveness and enhancing antibody engineering and vaccine design. Traditional machine learning methods have been w...

RLEAAI: improving antibody-antigen interaction prediction using protein language model and sequence order information.

Briefings in bioinformatics
Antibody-antigen interactions (AAIs) are a pervasive phenomenon in the natural and are instrumental in the design of antibody-based drugs. Despite the emergence of various deep learning-based methods aimed at enhancing the accuracy of AAIs prediction...

In silico proof of principle of machine learning-based antibody design at unconstrained scale.

mAbs
Generative machine learning (ML) has been postulated to become a major driver in the computational design of antigen-specific monoclonal antibodies (mAb). However, efforts to confirm this hypothesis have been hindered by the infeasibility of testing ...